Global Drugs for Non-small Cell Lung Cancer Market Analysis 2016-2020 and Forecast 2021-2027

  • Published Date : 26-08-2021
  • Pages : 138
  • Report Id : 53402
  • Categories : Healthcare

Snapshot

The global Drugs for Non-small Cell Lung Cancer market size is estimated at xxx million USD with a CAGR xx% from 2016-2021 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2027. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Non-small Cell Lung Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Radiofrequency Ablation (RFA)
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Sanofi
Ziopharm Oncology
Alchemia
Amgen
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Drugs for Non-small Cell Lung Cancer Industry
Figure Drugs for Non-small Cell Lung Cancer Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Drugs for Non-small Cell Lung Cancer
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Drugs for Non-small Cell Lung Cancer
1.2.2 Downstream
Table Application Segment of Drugs for Non-small Cell Lung Cancer
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2027, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Drugs for Non-small Cell Lung Cancer Market by Type
3.1 By Type
3.1.1 Radiofrequency Ablation (RFA) 
Table Major Company List of Radiofrequency Ablation (RFA) 
3.1.2 Radiation Therapy 
Table Major Company List of Radiation Therapy 
3.1.3 Chemotherapy 
Table Major Company List of Chemotherapy 
3.1.4 Targeted Therapies 
Table Major Company List of Targeted Therapies 
3.1.5 Immunotherapy
Table Major Company List of Immunotherapy
3.2 Market Size
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2021, by Type, in USD Million
Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2021, by Type, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2021, by Type, in Volume
Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2021, by Type, in Volume
3.3 Market Forecast
Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2027, by Type, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2027, by Type, in Volume
4 Major Companies List
4.1 Bristol-Myers Squibb  (Company Profile, Sales Data etc.)
4.1.1 Bristol-Myers Squibb  Profile
Table Bristol-Myers Squibb  Overview List
4.1.2 Bristol-Myers Squibb  Products & Services
4.1.3 Bristol-Myers Squibb  Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GlaxoSmithKline  (Company Profile, Sales Data etc.)
4.2.1 GlaxoSmithKline  Profile
Table GlaxoSmithKline  Overview List
4.2.2 GlaxoSmithKline  Products & Services
4.2.3 GlaxoSmithKline  Business Operation Conditions
Table Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Menarini  (Company Profile, Sales Data etc.)
4.3.1 Menarini  Profile
Table Menarini  Overview List
4.3.2 Menarini  Products & Services
4.3.3 Menarini  Business Operation Conditions
Table Business Operation of Menarini  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi  (Company Profile, Sales Data etc.)
4.4.1 Sanofi  Profile
Table Sanofi  Overview List
4.4.2 Sanofi  Products & Services
4.4.3 Sanofi  Business Operation Conditions
Table Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Ziopharm Oncology  (Company Profile, Sales Data etc.)
4.5.1 Ziopharm Oncology  Profile
Table Ziopharm Oncology  Overview List
4.5.2 Ziopharm Oncology  Products & Services
4.5.3 Ziopharm Oncology  Business Operation Conditions
Table Business Operation of Ziopharm Oncology  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Alchemia  (Company Profile, Sales Data etc.)
4.6.1 Alchemia  Profile
Table Alchemia  Overview List
4.6.2 Alchemia  Products & Services
4.6.3 Alchemia  Business Operation Conditions
Table Business Operation of Alchemia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amgen  (Company Profile, Sales Data etc.)
4.7.1 Amgen  Profile
Table Amgen  Overview List
4.7.2 Amgen  Products & Services
4.7.3 Amgen  Business Operation Conditions
Table Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Apotex  (Company Profile, Sales Data etc.)
4.8.1 Apotex  Profile
Table Apotex  Overview List
4.8.2 Apotex  Products & Services
4.8.3 Apotex  Business Operation Conditions
Table Business Operation of Apotex  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 BioMarin Pharmaceutical  (Company Profile, Sales Data etc.)
4.9.1 BioMarin Pharmaceutical  Profile
Table BioMarin Pharmaceutical  Overview List
4.9.2 BioMarin Pharmaceutical  Products & Services
4.9.3 BioMarin Pharmaceutical  Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 CellAct Pharma  (Company Profile, Sales Data etc.)
4.10.1 CellAct Pharma  Profile
Table CellAct Pharma  Overview List
4.10.2 CellAct Pharma  Products & Services
4.10.3 CellAct Pharma  Business Operation Conditions
Table Business Operation of CellAct Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Cerulean Pharma  (Company Profile, Sales Data etc.)
4.11.1 Cerulean Pharma  Profile
Table Cerulean Pharma  Overview List
4.11.2 Cerulean Pharma  Products & Services
4.11.3 Cerulean Pharma  Business Operation Conditions
Table Business Operation of Cerulean Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Cipla  (Company Profile, Sales Data etc.)
4.12.1 Cipla  Profile
Table Cipla  Overview List
4.12.2 Cipla  Products & Services
4.12.3 Cipla  Business Operation Conditions
Table Business Operation of Cipla  (Sales Revenue, Cost, Gross Margin)
4.13 Cornerstone Pharmaceuticals  (Company Profile, Sales Data etc.)
4.13.1 Cornerstone Pharmaceuticals  Profile
Table Cornerstone Pharmaceuticals  Overview List
4.13.2 Cornerstone Pharmaceuticals  Products & Services
4.13.3 Cornerstone Pharmaceuticals  Business Operation Conditions
Table Business Operation of Cornerstone Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Curis  (Company Profile, Sales Data etc.)
4.14.1 Curis  Profile
Table Curis  Overview List
4.14.2 Curis  Products & Services
4.14.3 Curis  Business Operation Conditions
Table Business Operation of Curis  (Sales Revenue, Cost, Gross Margin)
4.15 CytRx  (Company Profile, Sales Data etc.)
4.15.1 CytRx  Profile
Table CytRx  Overview List
4.15.2 CytRx  Products & Services
4.15.3 CytRx  Business Operation Conditions
Table Business Operation of CytRx  (Sales Revenue, Cost, Gross Margin)
4.16 Eli Lilly  (Company Profile, Sales Data etc.)
4.16.1 Eli Lilly  Profile
Table Eli Lilly  Overview List
4.16.2 Eli Lilly  Products & Services
4.16.3 Eli Lilly  Business Operation Conditions
Table Business Operation of Eli Lilly  (Sales Revenue, Cost, Gross Margin)
4.17 Exelixis  (Company Profile, Sales Data etc.)
4.17.1 Exelixis  Profile
Table Exelixis  Overview List
4.17.2 Exelixis  Products & Services
4.17.3 Exelixis  Business Operation Conditions
Table Business Operation of Exelixis  (Sales Revenue, Cost, Gross Margin)
4.18 Fresenius Kabi  (Company Profile, Sales Data etc.)
4.18.1 Fresenius Kabi  Profile
Table Fresenius Kabi  Overview List
4.18.2 Fresenius Kabi  Products & Services
4.18.3 Fresenius Kabi  Business Operation Conditions
Table Business Operation of Fresenius Kabi  (Sales Revenue, Cost, Gross Margin)
4.19 Genentech  (Company Profile, Sales Data etc.)
4.19.1 Genentech  Profile
Table Genentech  Overview List
4.19.2 Genentech  Products & Services
4.19.3 Genentech  Business Operation Conditions
Table Business Operation of Genentech  (Sales Revenue, Cost, Gross Margin)
4.20 Hikma Pharmaceuticals  (Company Profile, Sales Data etc.)
4.20.1 Hikma Pharmaceuticals  Profile
Table Hikma Pharmaceuticals  Overview List
4.20.2 Hikma Pharmaceuticals  Products & Services
4.20.3 Hikma Pharmaceuticals  Business Operation Conditions
Table Business Operation of Hikma Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
4.21 Hospira  (Company Profile, Sales Data etc.)
4.21.1 Hospira  Profile
Table Hospira  Overview List
4.21.2 Hospira  Products & Services
4.21.3 Hospira  Business Operation Conditions
Table Business Operation of Hospira  (Sales Revenue, Cost, Gross Margin)
4.22 Intas Pharmaceuticals  (Company Profile, Sales Data etc.)
4.22.1 Intas Pharmaceuticals  Profile
Table Intas Pharmaceuticals  Overview List
4.22.2 Intas Pharmaceuticals  Products & Services
4.22.3 Intas Pharmaceuticals  Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals  (Sales Revenue, Cost, Gross Margin)
4.23 Karyopharm Therapeutics  (Company Profile, Sales Data etc.)
4.23.1 Karyopharm Therapeutics  Profile
Table Karyopharm Therapeutics  Overview List
4.23.2 Karyopharm Therapeutics  Products & Services
4.23.3 Karyopharm Therapeutics  Business Operation Conditions
Table Business Operation of Karyopharm Therapeutics  (Sales Revenue, Cost, Gross Margin)
4.24 Kyowa Hakko Kirin  (Company Profile, Sales Data etc.)
4.24.1 Kyowa Hakko Kirin  Profile
Table Kyowa Hakko Kirin  Overview List
4.24.2 Kyowa Hakko Kirin  Products & Services
4.24.3 Kyowa Hakko Kirin  Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin  (Sales Revenue, Cost, Gross Margin)
4.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.)
4.25.1 Ligand Pharmaceuticals Profile
Table Ligand Pharmaceuticals Overview List
4.25.2 Ligand Pharmaceuticals Products & Services
4.25.3 Ligand Pharmaceuticals Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2016-2021, by Company, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share 2016-2021, by Company, in USD Million
Figure Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share in 2021, by Company, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume 2016-2021, by Company, in Volume
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share 2016-2021, by Company, in Volume
Figure Global Drugs for Non-small Cell Lung Cancer Sales Volume Share in 2021, by Company, in Volume
5.2 Regional Market by Company
Figure North America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2021
Figure Europe Drugs for Non-small Cell Lung Cancer Market Market Concentration, in 2021
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer MMarket Concentration, in 2021
Figure South America Drugs for Non-small Cell Lung Cancer Market Concentration, in 2021
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Concentration, in 2021
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital 
Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2021, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Hospital , 2016-2021, in Volume
6.1.2 Demand in Clinic 
Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2021, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Clinic , 2016-2021, in Volume
6.1.3 Demand in Others
Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2021, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Demand in Others, 2016-2021, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2027, by Application, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Market Growth 2021-2027, by Application, in USD Million
Figure Drugs for Non-small Cell Lung Cancer Market Share in 2027, by Application, in USD Million
Table Drugs for Non-small Cell Lung Cancer Demand Forecast 2021-2027, by Application, in Volume
Table Drugs for Non-small Cell Lung Cancer Market Growth 2021-2027, by Application, in Volume
Table Drugs for Non-small Cell Lung Cancer Market Share in 2027, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Drugs for Non-small Cell Lung Cancer Production 2016-2021, by Region, in USD Million
Table Drugs for Non-small Cell Lung Cancer Production 2016-2021, by Region, in Volume
7.2 Regional Market
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2021, by Region, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2021, by Region, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2021, by Region, in Volume
Table Global Drugs for Non-small Cell Lung Cancer Market Share 2016-2021, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in USD Million
Figure North America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in USD Million
Table North America Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in USD Million
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in USD Million
Table Europe Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in USD Million
Figure Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in USD Million
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in USD Million
Figure South America Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in USD Million
Table South America Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in USD Million
Figure Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth 2016-2021, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in USD Million
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Size 2016-2021, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2027, by Region, in USD Million
Table Drugs for Non-small Cell Lung Cancer Market Forecast 2021-2027, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2021 .